Fc-engineered anti-CTLA-4 monoclonal antibody

· Agenus Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fc-engineered anti-CTLA-4 monoclonal antibody, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer [Phase 1]